Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

Aggiornamento

Lo shock settico nei primi tre mesi di vita

Septic shock in the first three months of life

Sara Crestani1, Erica Passini1, Valentina Spaggiari1, Carlotta Toffoli1, Alessandra Boncompagni2, Luca Bedetti2,3, Eugenio Spaggiari2, Laura Lucaccioni4, Licia Lugli2, Federica Roversi2, Katia Rossi2, Lorenzo Iughetti4, Alberto Berardi2

1Scuola di Specializzazione in Pediatria, Azienda Ospedaliero-Universitaria Policlinico di Modena
2Terapia Intensiva Neonatale, AOU Policlinico di Modena
3PhD Program in Clinical and Experimental Medicine, Università di Modena e Reggio Emilia
4UO di Pediatria, AOU Policlinico di Modena

Novembre 2021 - pagg. 567 -575 | DOI: 10.53126/MEB40567

Abstract
Shock is a generalized tissue hypoperfusion that leads to severe cellular distress and complicates some cases of paediatric and neonatal sepsis. Although a reduction in associated sepsis mortality has been observed in the last decades, it remains one of the most important causes of death or long-term neurodevelopmental disabilities in children. Prompt recognition of this condition is therefore essential to improve survival and long-term outcome. The paediatrician and the neonatologist must therefore be able to promptly recognize the signs and symptoms of sepsis and septic shock to set up an adequate treatment according to the most recent international guidelines. This article provides epidemiological data from Italian and international studies, describes the pathophysiology and clinical manifestations of sepsis and septic shock, as well as the therapeutic indications according to very recent recommendations.
Riassunto
Lo shock settico è uno stato di ipoperfusione tissutale generalizzata che conduce a grave sofferenza cellulare e che complica una parte dei casi di sepsi pediatriche e neonatali. Nonostante negli ultimi decenni si sia osservata una riduzione della mortalità sepsi associata, essa rimane una della più importanti cause di decesso o esiti a lungo termine in età pediatrica. Il pronto riconoscimento di questa condizione è perciò essenziale per migliorare la sopravvivenza e l’outcome a lungo termine. Il pediatra e il neonatologo devono perciò essere in grado di riconoscere tempestivamente i segni e i sintomi di sepsi e shock settico per impostare un trattamento adeguato secondo le più recenti linee guida internazionali. Il presente articolo fornisce dati epidemiologici provenienti da studi italiani e internazionali, descrive la fisiopatologia e le manifestazioni cliniche della sepsi e dello shock settico, nonché le indicazioni terapeutiche secondo recentissime raccomandazioni.
Contenuto riservato

Per leggere l'articolo completo è necessario effettuare il login.

Non sei ancora registrato? Registrati

Bibliografia
1. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005;6(1):2-8. doi: 10.1097/01. PCC.0000149131.72248.E6. 2. Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals [published correction appears in Lancet 2017 May 13;389(10082):1884]. Lancet 2016;388(10063):3027-35. doi: 10.1016/S0140-6736(16)31593-8. 3. Wynn JL, Wong HR. Pathophysiology and treatment of septic shock in neonates. Clin Perinatol 2010;37(2):439-79. doi: 10.1016/j. clp.2010.04.002. 4. Berardi A, Sforza F, Baroni L, et al. Epidemiology and complications of late-onset sepsis: an Italian area-based study. PLoS One 2019;14(11):e0225407. doi: 10.1371/journal. pone.0225407. 5. Berardi A, Baroni L, Bacchi Reggiani ML, et al. The burden of early-onset sepsis in Emilia-Romagna (Italy): a 4-year, population-based study. J Matern Fetal Neonatal Med 2016;29 (19):3126-31. doi: 10.3109/14767058. 2015.1114093. 6. Weiss SL, Peters MJ, Alhazzani W, et al. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children. Pediatr Crit Care Med 2020;21(2): e52-e106. doi: 10.1097/PCC. 0000000000002198. 7. Agyeman PKA, Schlapbach LJ, Giannoni E, et al. Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study. Lancet Child Adolesc Health 2017;1(2):124-33. doi: 10.1016/S2352-4642(17)30010-X. 8. Polin AR, Abman SH, Rowitch DH, et al., Fetal and Neonatal Physiology, Elsevier, 2016, Volume 1, Fifth Edition, pp 1536-51. 9. Schrag SJ, Farley MM, Petit S, et al. Epidemiology of Invasive Early-Onset Neonatal Sepsis, 2005 to 2014. Pediatrics 2016;138(6): e20162013. doi: 10.1542/peds.2016-2013. 10. Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed 2011;96(1):F9-F14. doi: 10.1136/ adc.2009.178798. 11. Cailes B, Kortsalioudaki C, Buttery J, et al. Epidemiology of UK neonatal infections: the neonIN infection surveillance network. Arch Dis Child Fetal Neonatal Ed 2018;103 (6):F547-F553. doi: 10.1136/archdischild-2017-313203. 12. Carcillo JA. A synopsis of 2007 ACCM clinical practice parameters for hemodynamic support of term newborn and infant septic shock. Early Hum Dev 2014;90 Suppl 1:S45-S47. doi: 10.1016/S0378-3782(14)70015-5. 13. Schlapbach LJ, MacLaren G, Festa M, et al. Prediction of pediatric sepsis mortality within 1 h of intensive care admission. Intensive Care Med 2017;43(8):1085-96. doi: 10.1007/s00134-017-4701-8. 14. Davis AL, Carcillo JA, Aneja RK, et al. American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock [published correction appears in Crit Care Med 2017 Sep;45(9):e993. Kissoon, Niranjan Tex [corrected to Kissoon, Niranjan]; Weingarten-Abrams, Jacki [corrected to Weingarten-Arams, Jacki]]. Crit Care Med 2017;45(6):1061-93. doi: 10.1097/CCM. 0000000000002425. 15. Scott HF, Brou L, Deakyne SJ, Fairclough DL, Kempe A, Bajaj L. Lactate Clearance and Normalization and Prolonged Organ Dysfunction in Pediatric Sepsis. J Pediatr 2016;170: 149-55.e554. doi: 10.1016/j.jpeds.2015.11.071. 16. Hernández G, Ospina-Tascón GA, Damiani LP, et al. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial. JAMA 2019;321(7):654-64. doi: 10.1001/jama.2019.0071. 17. Sepsis: recognition, diagnosis and early management: © NICE (2017) Sepsis: recognition, diagnosis and early management. BJU Int 2018;121(4):497-514. doi: 10.1111/bju.14179. 18. Berardi A, Ficara M, Pietrella E, et al. Stewardship antimicrobica nel neonato e nel piccolo lattante. Perché e come praticarla. Medico e Bambino 2017;36(8):493-501. 19. Sullivan KV, Deburger B, Roundtree SS, Ventrola CA, Blecker-Shelly DL, Mortensen JE. Pediatric multicenter evaluation of the Verigene gram-negative blood culture test for rapid detection of inpatient bacteremia involving gram-negative organisms, extended-spectrum beta-lactamases, and carbapenemases. J Clin Microbiol 2014;52(7):2416-21. doi: 10.1128/JCM.00737-14. 20. Gies F, Tschiedel E, Felderhoff-Müser U, Rath PM, Steinmann J, Dohna-Schwake C. Prospective evaluation of SeptiFast Multiplex PCR in children with systemic inflammatory response syndrome under antibiotic treatment. BMC Infect Dis 2016;16:378. doi: 10.1186/s12879-016-1722-9. 21. Nelson AD, Bradley JS, Barnett ED, et al. 2020 Nelson’s Pediatric Antimicrobial Therapy. AAP, 2019, 26 th ed., pag. 124-5. 22. Vergnano S, Buttery J, Cailes B, et al.; ; Brighton Collaboration Neonatal Infections Working Group. Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine 2016;34(49):6038-46. doi: 10.1016/j.vaccine.2016.03.046. 23. Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev 2004;17(3):638-80, table of contents. doi: 10.1128/CMR.17.3.638-680.2004. 24. Russell MJ, Kanthimathinathan HK. Is There an Optimum Duration of Fluid Bolus in Pediatric Septic Shock? A Critical Appraisal of “Fluid Bolus Over 15-20 Versus 5-10 Minutes Each in the First Hour of Resuscitation in Children With Septic Shock: A Randomized Controlled Trial” by Sankar et al (Pediatr Crit Care Med 2017; 18:e435-e445). Pediatr Crit Care Med 2018;19(4):369-371. doi: 10.1097/PCC.0000000000001459. 25. Weiss SL, Keele L, Balamuth F, et al. Crystalloid Fluid Choice and Clinical Outcomes in Pediatric Sepsis: A Matched Retrospective Cohort Study. J Pediatr 2017;182:304-310.e10. doi: 10.1016/j.jpeds.2016.11.075. 26. Emrath ET, Fortenberry JD, Travers C, McCracken CE, Hebbar KB. Resuscitation With Balanced Fluids Is Associated With Improved Survival in Pediatric Severe Sepsis. Crit Care Med 2017;45(7):1177-83. doi: 10.1097/CCM.0000000000002365. 27. Arikan AA, Zappitelli M, Goldstein SL, Naipaul A, Jefferson LS, Loftis LL. Fluid overload is associated with impaired oxygenation and morbidity in critically ill children. Pediatr Crit Care Med 2012;13(3):253-8. doi: 10.1097/PCC.0b013e31822882a3. 28. Berardi A, Mariotti I, Pagano R, et al. Lo shock settico in età pediatrica. Medico e Bambino 2006;25(5):289-97. 29. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al; SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010;362(9):779-89. doi: 10.1056/ NEJMoa0907118. 30. Avni T, Lador A, Lev S, Leibovici L, Paul M, Grossman A. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis. PLoS One 2015;10(8):e0129305. doi: 10.1371/journal.pone.0129305. 31. Gamper G, Havel C, Arrich J, et al. Vasopressors for hypotensive shock. Cochrane Database Syst Rev. 2016 Feb 15;2(2):CD003709. doi: 10.1002/14651858.CD003709.pub4. 32. Baske K, Saini SS, Dutta S, Sundaram V. Epinephrine versus dopamine in neonatal septic shock: a double-blind randomized controlled trial. Eur J Pediatr 2018 Sep;177(9):1335-42. doi: 10.1007/s00431-018-3195-x. 33. Baske K, Saini SS, Dutta S, Sundaram V. Epinephrine versus dopamine in neonatal septic shock: a double-blind randomized controlled trial. Eur J Pediatr 2018;177(9):1335-1342. doi: 10.1007/s00431-018-3195-x. 34. Kluckow M, Seri I, Evans N. Functional echocardiography: an emerging clinical tool for the neonatologist. J Pediatr 2007;150(2): 125-30. doi: 10.1016/j.jpeds.2006.10.056.

Corrispondenza: alberto.berardi@unimore.it